# Abvc Biopharma, Inc.: Form 8-K, filed Oct 18, 2024

- Company: [Abvc Biopharma, Inc.](/companies/abvc.md) (CIK 1173313)
- Form: 8-K
- Filed: 2024-10-18
- Accepted by EDGAR: Oct 18, 2024, 17:23 ET
- Period: 2024-10-18
- Accession: 0001213900-24-089013
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1173313/000121390024089013/ea0218060-8k_abvcbio.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1173313/000121390024089013/

## Items reported

- Item 4.01: Change of auditor

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1173313/000121390024089013/ea0218060-8k_abvcbio.htm

Filed Oct 18, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-089013. Last ingested by Listed: Nov 2, 2026, 09:52 ET. No prices; not investment advice.